Teva Pharmaceutical Industries (TEVA) Change in Cash (2016 - 2025)
Historic Change in Cash for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $1.4 billion.
- Teva Pharmaceutical Industries' Change in Cash rose 761666.67% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $256.0 million, marking a year-over-year increase of 24594.59%. This contributed to the annual value of $256.0 million for FY2025, which is 24594.59% up from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Change in Cash stood at $1.4 billion for Q4 2025, which was up 761666.67% from $42.0 million recorded in Q3 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Change in Cash peaked at $1.4 billion during Q4 2025, and registered a low of -$1.6 billion during Q1 2025.
- Its 5-year average for Change in Cash is $69.0 million, with a median of $47.0 million in 2022.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Change in Cash tumbled by 136538.46% in 2023 and then surged by 761666.67% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Change in Cash (Quarter) stood at $153.0 million in 2021, then surged by 276.47% to $576.0 million in 2022, then surged by 69.62% to $977.0 million in 2023, then plummeted by 101.84% to -$18.0 million in 2024, then skyrocketed by 7616.67% to $1.4 billion in 2025.
- Its Change in Cash stands at $1.4 billion for Q4 2025, versus $42.0 million for Q3 2025 and $464.0 million for Q2 2025.